Immunized mice showed a substantial reduction in the vaccinia virus titer compared with control mice when the immunized mice were challenged with a recombinant vaccinia virus expressing HCV-NS5a genes.
Taken together, these observations are in agreement with the impairment in conditioned learning in response to a tone stimulus of aged APP/PS1 mice, although when immunized with EB101 during preventive or therapeutic periods, such impairments are significantly attenuated.
After 6 months of exposure, increased levels of anti-decorin and anti-collagen IgM antibodies were present in ECM immunized smoking mice when compared to control immunized smoking mice or control immunized sham smoke exposed mice.
After 6 months of exposure, increased numbers of anti-decorin IgM and IgG1 producing cells were present in both spleen and lung (only IgM) of ECM immunized smoking mice when compared to control immunized smoking mice or control immunized sham smoke exposed mice.
For decorin, there were also increased levels of IgG1 and IgG2a antibodies present in the ECM immunized smoke exposed mice when compared to control immunized smoking mice or control immunized sham smoke exposed mice.
For elastin, there was only an increase in IgM antibody levels in ECM immunized smoking mice when compared to control immunized sham smoke exposed mice.
For collagen there was an increase in IgM antibody producing cells in the lung and spleen (trend) in the ECM immunized smoking mice when compared to control immunized sham smoke exposed mice and in the lung there was a similar trend for elastin.
The trypanosome challenge experiment was aimed at determining the presence of a 'booster effect' of infection on the immune response (memory) in the immunized mice when compared with the control mice that were not immunized but infected with parasites.
Recently, recombinant B. subtilis spores expressing a fragment of the Helicobacter acinonychis UreB protein elicited a strong cellular immune response in orally immunized mice when co-administered with spores expressing IL-2 (Hinc et al., 2014).
When immunized mice started to show clinical symptoms, 30 arthritic mice (an animal exhibited a clinical score in the range of 1 to 3 on day 27) were chosen to receive different treatments and were randomly assigned in cages.
